What are the side effects of PLUVICTO 1 000 MBq/mL, solution injectable/pour perfusion?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can PLUVICTO 1 000 MBq/mL, solution injectable/pour perfusion be used during pregnancy?

( AHT ) For the active ingredient lutetium (177-lu) vipivotide tetraxetan This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures PLUVICTO 1 000 MBq/mL, solution injectable/pour perfusion?

NOVARTIS EUROPHARM (IRLANDE) (FR)

OTC

PLUVICTO 1 000 MBq/mL, solution injectable/pour perfusion

INN: LUTÉCIUM (177LU) VIPIVOTIDE TÉTRAXÉTAN

Data updated: 2026-04-11

Available in:

🇩🇪🇬🇧🇫🇷

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.